References
Haroche J, Arnaud L, Cohen-Aubart F, Hervier B, Charlotte F, Emile JF et al (2014) Erdheim-Chester disease. Curr Rheumatol Rep 16:412
Conley A, Manjila S, Guan H, Guthikonda M, Kupsky WJ, Mittal S (2010) Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease. Neuropathology 30:634–647
Haroche J, Cohen-Aubart F, Emile JF, Maksud P, Drier A, Tolédano D et al (2015) Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. J Clin Oncol 33:411–418
Drier A, Haroche J, Savatovsky J, Godenèche G, Dormont D, Chiras J et al (2010) Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology 255:586–594
Tien RD, Brasch RC, Jackson DE, Dillon WP (1989) Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images. Radiology 172:791–792
Oweity T, Scheithauer BW, Ching HS, Lei C, Wong KP (2002) Multiple system Erdheim-Chester disease with massive hypothalamic-sellar involvement and hypopituitarism. J Neurosurg 96:344–351
Thorns V, Zajaczek J, Becker H, Walter GF, Hori A (2003) Extracerebral subdural manifestation of Chester-Erdheim disease associated with a giant adenoma of the pituitary. Clin Neuropathol 22:246–251
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Kon, T., Nishijima, H., Kon, H. et al. Erdheim–Chester disease: yellow-tinge appearance on neuroendoscopic imaging. Neurol Sci 36, 2159–2160 (2015). https://doi.org/10.1007/s10072-015-2331-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2331-x